Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
5.44
+0.16 (3.03%)
Nov 21, 2024, 4:00 PM EST - Market closed

Orchestra BioMed Holdings Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
207326112206262
Market Cap Growth
-37.62%191.65%-45.72%-21.31%-
Enterprise Value
136229193--
Last Close Price
5.289.139.9810.0812.81
PS Ratio
71.99118.2431.67-263.6045.93
PB Ratio
4.334.802.13-10.4290.02
P/TBV Ratio
4.214.802.13--
EV/Sales Ratio
51.2482.9554.51--
Debt / Equity Ratio
0.040.020.23-0.293.25
Asset Turnover
0.030.030.06--
Inventory Turnover
1.040.881.232.91-
Quick Ratio
4.137.824.520.902.50
Current Ratio
4.237.954.560.922.52
Return on Equity (ROE)
-91.66%-81.47%-205.21%--
Return on Assets (ROA)
-39.20%-33.75%-37.42%-52.79%-
Return on Capital (ROIC)
-53.98%-48.00%-81.16%--
Earnings Yield
-28.10%-15.05%-30.03%-11.16%-8.15%
FCF Yield
-23.47%-14.16%-26.70%-9.56%-10.20%
Buyback Yield / Dilution
-22.34%-121.67%-609.97%-4.86%-
Total Shareholder Return
-22.34%-121.67%-609.97%-4.86%-
Source: S&P Capital IQ. Standard template. Financial Sources.